FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022868082> ?p ?o ?g. }

• W2022868082 endingPage "151" @default.
• W2022868082 startingPage "143" @default.
• W2022868082 abstract "In the present study, we have investigated the potential of a nanoemulsion (thermodynamically stable transparent dispersions of oil and water having a droplet size <200 nm) formulation for the topical delivery of COX-2 inhibitors using etoricoxib as a model drug. Various oil-in-water nanoemulsions were prepared by the spontaneous emulsification method. The nanoemulsion area was identified by constructing pseudo-ternary phase diagrams. The prepared nanoemulsions were subjected to thermodynamic stability testing. Those that passed these tests were characterized for viscosity, droplet size and differential scanning calorimetry. Topical permeation of etoricoxib through porcine abdominal skin was estimated using the Franz diffusion cell. The ex vivo skin permeation profile of optimized formulations was compared with that of etoricoxib conventional gel. A significant increase in permeability was observed in optimized nanoemulsion formulations consisting of 2 % w/w of etoricoxib, 20 % w/w of Triacetin, 38 % w/w of a surfactant mixture (Cremophor RH 40:Transcutol P), and 42 % w/w of water. The anti-inflammatory effects of this formulation on carrageenan-induced paw edema in rats showed a significant increase in the percent inhibition value (84.61 % with the nanoemulsion gel and 92.30 % with the nanoemulsion) as compared with the conventional gel (69.23 %) after 6 h when compared with etoricoxib conventional gel. These results suggest that nanoemulsions can serve as potential vehicles for improved transdermal delivery of anti-inflammatory agents such as etoricoxib." @default.
• W2022868082 created "2016-06-24" @default.
• W2022868082 creator A5040598852 @default.
• W2022868082 creator A5047514897 @default.
• W2022868082 date "2013-01-19" @default.
• W2022868082 modified "2023-10-16" @default.
• W2022868082 title "Nanoemulsion-based gel formulations of COX-2 inhibitors for enhanced efficacy in inflammatory conditions" @default.
• W2022868082 cites W131700691 @default.
• W2022868082 cites W1573102918 @default.
• W2022868082 cites W1964118137 @default.
• W2022868082 cites W1972353309 @default.
• W2022868082 cites W1981493239 @default.
• W2022868082 cites W1985142393 @default.
• W2022868082 cites W1989400276 @default.
• W2022868082 cites W1997506087 @default.
• W2022868082 cites W2008897710 @default.
• W2022868082 cites W2017942706 @default.
• W2022868082 cites W2026537351 @default.
• W2022868082 cites W2034496890 @default.
• W2022868082 cites W2038443503 @default.
• W2022868082 cites W2061440920 @default.
• W2022868082 cites W2064910281 @default.
• W2022868082 cites W2075994202 @default.
• W2022868082 cites W2080390434 @default.
• W2022868082 cites W2080768357 @default.
• W2022868082 cites W2082372964 @default.
• W2022868082 cites W2092705634 @default.
• W2022868082 cites W2100520064 @default.
• W2022868082 cites W2112543032 @default.
• W2022868082 cites W2122866830 @default.
• W2022868082 cites W230217728 @default.
• W2022868082 cites W2314290435 @default.
• W2022868082 cites W288523926 @default.
• W2022868082 cites W4235651377 @default.
• W2022868082 doi "https://doi.org/10.1007/s13204-012-0177-6" @default.
• W2022868082 hasPublicationYear "2013" @default.
• W2022868082 type Work @default.
• W2022868082 sameAs 2022868082 @default.
• W2022868082 citedByCount "43" @default.
• W2022868082 countsByYear W20228680822014 @default.
• W2022868082 countsByYear W20228680822015 @default.
• W2022868082 countsByYear W20228680822016 @default.
• W2022868082 countsByYear W20228680822017 @default.
• W2022868082 countsByYear W20228680822018 @default.
• W2022868082 countsByYear W20228680822019 @default.
• W2022868082 countsByYear W20228680822020 @default.
• W2022868082 countsByYear W20228680822021 @default.
• W2022868082 countsByYear W20228680822022 @default.
• W2022868082 countsByYear W20228680822023 @default.
• W2022868082 crossrefType "journal-article" @default.
• W2022868082 hasAuthorship W2022868082A5040598852 @default.
• W2022868082 hasAuthorship W2022868082A5047514897 @default.
• W2022868082 hasBestOaLocation W20228680821 @default.
• W2022868082 hasConcept C121332964 @default.
• W2022868082 hasConcept C178790620 @default.
• W2022868082 hasConcept C185592680 @default.
• W2022868082 hasConcept C192562407 @default.
• W2022868082 hasConcept C205679159 @default.
• W2022868082 hasConcept C2776214540 @default.
• W2022868082 hasConcept C2779040406 @default.
• W2022868082 hasConcept C2780820201 @default.
• W2022868082 hasConcept C39519442 @default.
• W2022868082 hasConcept C41625074 @default.
• W2022868082 hasConcept C43617362 @default.
• W2022868082 hasConcept C50670333 @default.
• W2022868082 hasConcept C55493867 @default.
• W2022868082 hasConcept C71924100 @default.
• W2022868082 hasConcept C97355855 @default.
• W2022868082 hasConcept C98274493 @default.
• W2022868082 hasConceptScore W2022868082C121332964 @default.
• W2022868082 hasConceptScore W2022868082C178790620 @default.
• W2022868082 hasConceptScore W2022868082C185592680 @default.
• W2022868082 hasConceptScore W2022868082C192562407 @default.
• W2022868082 hasConceptScore W2022868082C205679159 @default.
• W2022868082 hasConceptScore W2022868082C2776214540 @default.
• W2022868082 hasConceptScore W2022868082C2779040406 @default.
• W2022868082 hasConceptScore W2022868082C2780820201 @default.
• W2022868082 hasConceptScore W2022868082C39519442 @default.
• W2022868082 hasConceptScore W2022868082C41625074 @default.
• W2022868082 hasConceptScore W2022868082C43617362 @default.
• W2022868082 hasConceptScore W2022868082C50670333 @default.
• W2022868082 hasConceptScore W2022868082C55493867 @default.
• W2022868082 hasConceptScore W2022868082C71924100 @default.
• W2022868082 hasConceptScore W2022868082C97355855 @default.
• W2022868082 hasConceptScore W2022868082C98274493 @default.
• W2022868082 hasIssue "2" @default.
• W2022868082 hasLocation W20228680821 @default.
• W2022868082 hasOpenAccess W2022868082 @default.
• W2022868082 hasPrimaryLocation W20228680821 @default.
• W2022868082 hasRelatedWork W1980138230 @default.
• W2022868082 hasRelatedWork W1994290550 @default.
• W2022868082 hasRelatedWork W2022868082 @default.
• W2022868082 hasRelatedWork W2125142031 @default.
• W2022868082 hasRelatedWork W2189012280 @default.
• W2022868082 hasRelatedWork W2351802131 @default.
• W2022868082 hasRelatedWork W2572302698 @default.
• W2022868082 hasRelatedWork W2965994210 @default.
• W2022868082 hasRelatedWork W2982144557 @default.

• next